{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:10:14Z","timestamp":1761156614222},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.2169\/internalmedicine.1899-18","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T22:34:33Z","timestamp":1547073273000},"page":"1225-1231","source":"Crossref","is-referenced-by-count":14,"title":["Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia\/Gout"],"prefix":"10.2169","volume":"58","author":[{"given":"Akiko","family":"Katayama","sequence":"first","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohide","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Health Screening, Tokyo Health Service Association, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Isonuma","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Hisaoka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Frohlich ED. Uric acid. A risk factor for coronary heart disease. JAMA 270: 378-379, 1993.","DOI":"10.1001\/jama.270.3.378"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821, 2008.","DOI":"10.1056\/NEJMra0800885"},{"key":"3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1440-1797.2011.01513.x","volume":"16","author":"S Wang","year":"2011","unstructured":"3. Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Nephrology 16: 767-776, 2011.","journal-title":"Nephrology","ISSN":"http:\/\/id.crossref.org\/issn\/1320-5358","issn-type":"print"},{"key":"4","unstructured":"4. Nagahama K, Inoue T, Kohagura K, Ishihara A, Kinjo K, Ohya Y. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res 37: 232-238, 2014."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001.","DOI":"10.1161\/hy1101.092839"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002.","DOI":"10.1097\/01.ASN.0000034910.58454.FD"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: 625-631, 2006.","DOI":"10.1152\/ajprenal.00140.2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lim SY, Lu N, Oza A, et al. Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993-2011. JAMA 315: 2345-2347, 2016.","DOI":"10.1001\/jama.2016.3517"},{"key":"9","unstructured":"9. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: 2nd ed. 2012 [Internet]. [cited 2018 Jun. 15]. Available from: http:\/\/www.tukaku.jp\/wp-content\/uploads\/2013\/06\/tufu-GL2.pdf (in Japanese)."},{"key":"10","unstructured":"10. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51: 321-325, 2004."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Iseki K, Oshiro S, Tozawa M, Ikemiya Y, Fukiyama K, Takishita S. Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res 25: 185-190, 2002.","DOI":"10.1291\/hypres.25.185"},{"key":"12","unstructured":"12. Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent gout: a systematic review. J Rheumatol 44: 388-396, 2017."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cut points. Clin Chem 36: 15-19, 1990.","DOI":"10.1093\/clinchem\/36.1.15"},{"key":"14","unstructured":"14. Kashiwagi A, Kasuga M, Araki E, et al. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 3: 39-40, 2012."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med 1: 409-421, 1972.","DOI":"10.1016\/0091-7435(72)90014-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yokokawa H, Goto A, Sanada H, et al. Achievement status toward goal blood pressure levels and healthy lifestyles among Japanese hypertensive patients; cross sectional survey results from Fukushima Research of Hypertension (FRESH). Intern Med 50: 1149-1156, 2011.","DOI":"10.2169\/internalmedicine.50.4969"},{"key":"17","unstructured":"17. Hosoya T, Sasaki T, Ohashi T. Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study. Clin Rheumatol 36: 649-656, 2017."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto T, Hidaka Y, Inaba M, et al. Effects of febuxostat on serum urate level in Japanese hyperuricemia patients. Mod Rheumatol 25: 779-783, 2015.","DOI":"10.3109\/14397595.2015.1016257"},{"key":"19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1797.2011.01446.x","volume":"16","author":"I Nakaya","year":"2011","unstructured":"19. Nakaya I, Namikoshi T, Tsuruta Y, et al. Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey. Nephrology 16: 518-521, 2011.","journal-title":"Nephrology","ISSN":"http:\/\/id.crossref.org\/issn\/1320-5358","issn-type":"print"},{"key":"20","unstructured":"20. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med 125: 882-887, 2012."},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Nakanishi N, Yoshida H, Nakamura K, Suzuki K, Tatara K. Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men. Metabolism 50: 621-626, 2001.","DOI":"10.1053\/meta.2001.24196"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim TH, Lee SS, Yoo JH, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr 4: 3, 2012.","DOI":"10.1186\/1758-5996-4-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dalbeth N, Phipps-Green A, House ME, et al. Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. Arthritis Res Ther 17: 263, 2015.","DOI":"10.1186\/s13075-015-0781-4"},{"key":"24","unstructured":"24. Nielsen SM, Bartels EM, Henriksen M, et al. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis 76: 1870-1882, 2017."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Zhu Y, Zhang Y, Choi HK. The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology 49: 2391-2399, 2010.","DOI":"10.1093\/rheumatology\/keq256"},{"key":"26","unstructured":"26. Fu S, Luo L, Ye P, Xiao W. Epidemiological associations between hyperuricemia and cardiometabolic risk factors: a comprehensive study from Chinese community. BMC Cardiovasc Disord 15: 129, 2015."},{"key":"27","unstructured":"27. Kuwabara M, Borghi C, Cicero AFG, et al. Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: a five-year cohort study in Japan. Int J Cardiol 261: 183-188, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_1899-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T04:58:30Z","timestamp":1606021110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_1899-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1899-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}